Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute renal disease in vasculitis.

J S Cameron1

  • 1Clinical Science Laboratories, Guy's Hospital, London, United Kingdom.

Annales De Medecine Interne
|January 1, 1988
PubMed
Summary

Vasculitis, often presenting with diverse symptoms, affects the kidneys. Modern immunosuppressive treatments have significantly improved outcomes for severe renal vasculitis, like Wegener

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial juvenile hyperuricaemic nephropathy is not such a rare genetic metabolic purine disease in Britain.

Nucleosides, nucleotides & nucleic acids·2006
Same author

The discovery of diabetic nephropathy: from small print to centre stage.

Journal of nephrology·2006
Same author

Familial juvenile hyperuricaemic nephropathy.

QJM : monthly journal of the Association of Physicians·2004
Same author

Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.

QJM : monthly journal of the Association of Physicians·2002
Same author

Characteristics and outcome of membranous nephropathy in older patients.

International urology and nephrology·2002
Same author

The continued care of children with renal disease into adult life.

Pediatric nephrology (Berlin, Germany)·2001

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Vasculitis encompasses a diverse group of inflammatory conditions affecting blood vessels.
  • Renal involvement is a significant manifestation of systemic vasculitis.
  • Understanding the pathogenesis and treatment of renal vasculitis is crucial for patient outcomes.

Purpose of the Study:

  • To outline a classification and diagnostic approach for vasculitis, with a focus on renal involvement.
  • To summarize recent advancements in understanding vasculitis pathogenesis, particularly cell-mediated immunity.
  • To review current treatment strategies for renal vasculitis and associated renal insufficiency.

Main Methods:

  • Review of recent literature on vasculitis and renal vasculitis.
  • Summary of established and emerging treatment modalities.
  • Discussion of pathogenetic mechanisms, including cell-mediated immunity.

Main Results:

  • Improved prognosis for severe renal vasculitis (e.g., Wegener's granulomatosis, microscopic polyarteritis) over 30 years.
  • Effective immunosuppressive therapies include corticosteroids, cytotoxic agents, and plasma exchange.
  • Dialysis serves as supportive care for renal insufficiency.

Conclusions:

  • Long-term management of immunosuppression in survivors of severe renal vasculitis presents ongoing challenges.
  • Advances in treatment have significantly enhanced survival rates for patients with renal vasculitis.
  • Continued research is needed to optimize long-term immunosuppressive strategies and minimize side effects.

Related Experiment Videos